Price $2.27 |
Market Cap
74.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
0.4
|
P/B
2.03
|
P/S
2.27
|
Dividend %
-
|
|
P/CF
2.4
|
P/FCF
4.1
|
Op. Cash Flow
3.7K
|
FCF
0.5
|
|
Op. Margin
-14.30%
|
Net Margin
-18.70%
|
ROE
-20.60%
|
ROI
29.00%
|
|
ROA
-13.40%
|
EPS Growth
85.80%
|
Current Ratio
1.4
|
Debt/Equity
35.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH) | $120.60 | - | 0.80% | 23.46B | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.04 | - | - | 48.9M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $1.87 | - | - | 72.7M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $6.30 | - | - | 106.5M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $45.51 | - | - | 1.31B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
